1.	Hormonal Therapy with Tamoxifen vs Aminoglutethimide and Dexamethasone vs Adrenalectomy for Metastatic Breast Adenocarcinoma Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-2176
2.	Phase II Mitotane plus Cortisone Acetate/Fludrocortisone and ADR for Residual, Recurrent, or Metastatic Adrenal Cortical Carcinoma Phase: Phase II Type: Treatment Status: Completed Age: 18 to 75 Sponsor: NCI Protocol IDs: EST-1879
3.	Phase II Chemotherapy with Mitotane/CACP for Metastatic or Residual Unresectable Adrenal Carcinoma Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-8325, SEG-INT-GU-217
4.	Phase II Hormone Therapy with Aminoglutethimide in Patients with Relapsed Stage III/IV Ovarian Cancer Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAOP-7284
5.	Phase II Randomized Second-Line Endocrine Therapy with AG/HC vs AG vs Low-Dose AG vs Low-Dose AG/HC vs HC in Patients with Advanced Breast Cancer Phase: Phase II Type: Treatment Status: Closed Age: postmenopausal Sponsor: Protocol IDs: EORTC-10861
6.	Phase I Study of SUR in Patients with Advanced Cancer (Summary Last Modified 11/98) Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UCCRC-6274, NCI-T91-0212C, T91-0212
7.	Orchiectomy with or without Subsequent Adrenalectomy for Metastatic Cancer of the Male Breast and Adjuvant Therapy for Stage II Male Breast Cancer Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-76-C-198, NCI-MB-82, NCI-T83-1248N, T83-1248